Mirati Therapeutics: Q1 Earnings Insights

Loading...
Loading...

Mirati Therapeutics MRTX reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Mirati Therapeutics beat estimated earnings by 10.42%, reporting an EPS of $-3.18 versus an estimate of $-3.55.

Revenue was up $6.46 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.04 which was followed by a 1.96% drop in the share price the next day.

Here's a look at Mirati Therapeutics's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -3.55 -3.48 -3.49 -3.49
EPS Actual -3.51 -3.09 -3.18 -3.40
Revenue Estimate 2.27M 1.26M 340K 160K
Revenue Actual 934K 5.43M 5.36M 709K

To track all earnings releases for Mirati Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...